{"id":"https://openalex.org/W2073697159","doi":"https://doi.org/10.1001/archderm.139.8.1045","title":"Eruptive Xanthomas Associated With Olanzapine Use","display_name":"Eruptive Xanthomas Associated With Olanzapine Use","publication_year":2003,"publication_date":"2003-08-01","ids":{"openalex":"https://openalex.org/W2073697159","doi":"https://doi.org/10.1001/archderm.139.8.1045","mag":"2073697159","pmid":"https://pubmed.ncbi.nlm.nih.gov/12925394"},"language":"en","primary_location":{"id":"doi:10.1001/archderm.139.8.1045","doi":"https://doi.org/10.1001/archderm.139.8.1045","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archderm.139.8.1045","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040230088","display_name":"Howard Y. Chang","orcid":"https://orcid.org/0000-0002-9459-4393","observed_orcids":["https://orcid.org/0000-0002-9459-4393"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Y. Chang","raw_affiliation_strings":["Department of Dermatology, Program in Epithelial Biology, Stanford University School of Medicine, Stanford, Calif. 94305, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Program in Epithelial Biology, Stanford University School of Medicine, Stanford, Calif. 94305, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085814203","display_name":"Todd W. Ridky","orcid":"https://orcid.org/0000-0001-8482-1284","observed_orcids":["https://orcid.org/0000-0001-8482-1284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Todd W. Ridky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059337854","display_name":"Alexa B. Kimball","orcid":"https://orcid.org/0000-0001-9405-0479","observed_orcids":["https://orcid.org/0000-0001-9405-0479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra B. Kimball","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081268955","display_name":"Elizabeth C. Hughes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Hughes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030774402","display_name":"Anthony E. Oro","orcid":"https://orcid.org/0000-0002-6261-138X","observed_orcids":["https://orcid.org/0000-0002-6261-138X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony E. Oro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6338,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.82620899,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"139","issue":"8","first_page":"1045","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8285999894142151,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8285999894142151,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":0.13830000162124634,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eruptive-xanthoma","display_name":"eruptive xanthoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9160000085830688},{"id":"https://openalex.org/keywords/insulin-deficiency","display_name":"insulin deficiency","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-induced-skin-disease","display_name":"drug-induced skin disease","score":0.4880000054836273},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.800000011920929},{"id":"https://openalex.org/keywords/metabolic-side-effects","display_name":"metabolic side effects","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9627140760421753},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8688453435897827},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8133811950683594},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.6033946871757507},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.59371417760849},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5849379301071167},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5666202306747437},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.49319761991500854},{"id":"https://openalex.org/C160146798","wikidata":"https://www.wikidata.org/wiki/Q2471453","display_name":"Psychogenic disease","level":2,"score":0.4497489929199219},{"id":"https://openalex.org/C2910202354","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic Agent","level":4,"score":0.4146782457828522},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3841142952442169},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3073452413082123},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.29597657918930054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2631712555885315},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1503412425518036},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.08866333961486816},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014973","descriptor_name":"Xanthomatosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D014973","descriptor_name":"Xanthomatosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1001/archderm.139.8.1045","doi":"https://doi.org/10.1001/archderm.139.8.1045","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archderm.139.8.1045","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},{"id":"pmid:12925394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12925394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of dermatology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W56516037","https://openalex.org/W91051758","https://openalex.org/W184628882","https://openalex.org/W1529638792","https://openalex.org/W1712554668","https://openalex.org/W1839826402","https://openalex.org/W1906349732","https://openalex.org/W1969707286","https://openalex.org/W1987632018","https://openalex.org/W1992774139","https://openalex.org/W1994924067","https://openalex.org/W1995203392","https://openalex.org/W2001701208","https://openalex.org/W2012424893","https://openalex.org/W2015631227","https://openalex.org/W2015990374","https://openalex.org/W2021547003","https://openalex.org/W2031755348","https://openalex.org/W2039239004","https://openalex.org/W2043033216","https://openalex.org/W2048069261","https://openalex.org/W2051423367","https://openalex.org/W2063722177","https://openalex.org/W2079567719","https://openalex.org/W2079595233","https://openalex.org/W2082754471","https://openalex.org/W2085476035","https://openalex.org/W2114637662","https://openalex.org/W2126317966","https://openalex.org/W2136957299","https://openalex.org/W2136962131","https://openalex.org/W2187772766","https://openalex.org/W2328991947","https://openalex.org/W2437676140","https://openalex.org/W2438708287","https://openalex.org/W4235099202"],"related_works":["https://openalex.org/W2398606609","https://openalex.org/W2768040646","https://openalex.org/W7217779522","https://openalex.org/W2801548178","https://openalex.org/W3175644853","https://openalex.org/W2017321989","https://openalex.org/W7217057429","https://openalex.org/W4413203288","https://openalex.org/W2741367035","https://openalex.org/W7216789862"],"abstract_inverted_index":{"BACKGROUND:":[0],"Since":[1],"their":[2],"introduction":[3],"to":[4],"the":[5,19,32,45,51,58,89,102,110,113,123],"US":[6],"market,":[7],"atypical":[8,106],"antipsychotic":[9,107],"drugs,":[10],"such":[11],"as":[12],"olanzapine,":[13],"have":[14,24,41],"been":[15,26,42],"widely":[16],"prescribed":[17],"for":[18,31,125],"management":[20],"of":[21,34,47,53,75,91,105],"psychosis":[22],"and":[23,39,57],"increasingly":[25],"used":[27],"in":[28,97,109,117,129],"dermatologic":[29,111],"settings":[30],"treatment":[33],"psychogenic":[35],"dermatoses.":[36],"Mild":[37],"hyperglycemia":[38],"hypertriglyceridemia":[40],"documented":[43],"from":[44],"use":[46,96,104,121],"these":[48],"medications,":[49],"but":[50],"range":[52],"effects":[54,59],"on":[55,60],"metabolism":[56],"skin":[61],"are":[62],"poorly":[63],"characterized.":[64],"OBSERVETION:":[65],"We":[66],"describe":[67],"3":[68],"patients":[69],"who":[70],"developed":[71],"eruptive":[72],"xanthomas,":[73],"1":[74],"whom":[76],"had":[77],"relative":[78],"insulin":[79],"insufficiency,":[80],"after":[81],"starting":[82],"olanzapine":[83,95,120],"therapy.":[84],"These":[85],"cases":[86],"further":[87],"support":[88],"association":[90,118],"severe":[92],"dyslipidemia":[93,114],"with":[94,119],"selected":[98],"patients.":[99,131],"CONCLUSION:":[100],"With":[101],"increasing":[103],"agents":[108],"setting,":[112],"that":[115],"develops":[116],"emphasizes":[122],"need":[124],"periodic":[126],"metabolic":[127],"studies":[128],"high-risk":[130]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}